Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19

The potential emergence of SARS-CoV-2 variants capable of escaping vaccine-generated immune responses poses a looming threat to vaccination efforts and will likely prolong the duration of the COVID-19 pandemic. Additionally, the prevalence of beta coronaviruses circulating in animals and the precede...

Descripción completa

Detalles Bibliográficos
Autores principales: Malek, Rory J., Bill, Colin A., Vines, Charlotte M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486678/
https://www.ncbi.nlm.nih.gov/pubmed/34624681
http://dx.doi.org/10.1016/j.biopha.2021.112276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486678/
https://www.ncbi.nlm.nih.gov/pubmed/34624681
http://dx.doi.org/10.1016/j.biopha.2021.112276

Ejemplares similares